|
TMEM106C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.402290E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.726200E-02 |
| Normal-vs-Stage2 |
7.832600E-01 |
| Normal-vs-Stage3 |
4.576000E-04 |
| Normal-vs-Stage4 |
1.129550E-02 |
| Stage1-vs-Stage2 |
4.040200E-01 |
| Stage1-vs-Stage3 |
4.319700E-02 |
| Stage1-vs-Stage4 |
2.127200E-01 |
| Stage2-vs-Stage3 |
1.518190E-01 |
| Stage2-vs-Stage4 |
2.139800E-01 |
| Stage3-vs-Stage4 |
6.654000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.379920E-02 |
| Normal-vs-AfricanAmerican |
2.401800E-01 |
| Normal-vs-Asian |
6.946400E-01 |
| Caucasian-vs-AfricanAmerican |
8.892200E-01 |
| Caucasian-vs-Asian |
8.624000E-01 |
| AfricanAmerican-vs-Asian |
9.113600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.175600E-02 |
| Normal-vs-Female |
4.160100E-02 |
| Male-vs-Female |
7.006600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.029100E-04 |
| Normal-vs-Age(41-60Yrs) |
8.340000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.444900E-03 |
| Normal-vs-Age(81-100Yrs) |
4.743800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.300380E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.198000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.169650E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.926400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.096600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.378800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.525900E-02 |
| Normal-vs-Grade 2 |
1.209380E-01 |
| Normal-vs-Grade 3 |
7.621800E-03 |
| Normal-vs-Grade 4 |
2.736100E-03 |
| Grade 1-vs-Grade 2 |
2.297600E-01 |
| Grade 1-vs-Grade 3 |
4.697000E-01 |
| Grade 1-vs-Grade 4 |
7.107400E-01 |
| Grade 2-vs-Grade 3 |
4.648800E-01 |
| Grade 2-vs-Grade 4 |
1.114990E-01 |
| Grade 3-vs-Grade 4 |
2.239600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.518300E-02 |
| Normal-vs-ccB subtype |
1.659980E-01 |
| ccA subtype-vs-ccB subtype |
7.930000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.908440E-01 |
| Normal-vs-N1 |
9.702200E-02 |
| N0-vs-N1 |
3.834000E-01 |
|
|
